1. NHS Choices. Prostate problems [Internet]. 2024 [cited 2024 Oct 30]. Available from:
https://www.nhs.uk/conditions/prostate-problems/3. Matsushita M, Fujita K, Norio Nonomura. Influence of Diet and Nutrition on Prostate Cancer. International Journal of Molecular Sciences [Internet]. 2020 Feb 20 [cited 2024 Oct 30];21(4):1447–7. Available from:
https://pmc.ncbi.nlm.nih.gov/articles/PMC7073095/8. Wei MY, Giovannucci EL. Lycopene, Tomato Products, and Prostate Cancer Incidence: A Review and Reassessment in the PSA Screening Era. Journal of Oncology [Internet]. 2012 Jan 1 [cited 2024 Oct 30];2012:1–7. Available from:
https://pmc.ncbi.nlm.nih.gov/articles/PMC3368367/10. Arballo J, Amengual J, Erdman JW. Lycopene: A Critical Review of Digestion, Absorption, Metabolism, and Excretion. Antioxidants [Internet]. 2021 Feb 25 [cited 2024 Oct 30];10(3):342–2. Available from:
https://pmc.ncbi.nlm.nih.gov/articles/PMC7996133/11. Long J, Liu Z, Liang S, Chen B. Cruciferous Vegetable Intake and Risk of Prostate Cancer: A Systematic Review and Meta-Analysis. Urologia Internationalis [Internet]. 2023 Jan 1 [cited 2024 Oct 30];107(7):723–33. Available from:
https://pubmed.ncbi.nlm.nih.gov/37343525/12. Ferreira PMP, Rodrigues LARL, Paula, Paulo, Michel L, Nunes NMF, et al. Cruciferous Vegetables as Antioxidative, Chemopreventive and Antineoplasic Functional Foods: Preclinical and Clinical Evidences of Sulforaphane Against Prostate Cancers. Current Pharmaceutical Design [Internet]. 2019 Jan 18 [cited 2024 Oct 30];24(40):4779–93. Available from:
https://pubmed.ncbi.nlm.nih.gov/30652644/13. Ballon-Landa E, Parsons JK. Nutrition, physical activity, and lifestyle factors in prostate cancer prevention. Current Opinion in Urology [Internet]. 2017 Oct 18 [cited 2024 Oct 30];28(1):55–61. Available from:
https://pubmed.ncbi.nlm.nih.gov/29049045/14. Zuniga KB, Chan JM, Ryan CJ, Kenfield SA. Diet and lifestyle considerations for patients with prostate cancer. Urologic Oncology Seminars and Original Investigations [Internet]. 2019 Jul 18 [cited 2024 Oct 30];38(3):105–17. Available from:
https://pubmed.ncbi.nlm.nih.gov/31327752/16. Burcu Erbaykent Tepedelen, Soya E, Korkmaz M. Epigallocatechin-3-gallate reduces the proliferation of benign prostatic hyperplasia cells via regulation of focal adhesions. Life Sciences [Internet]. 2017 Oct 12 [cited 2024 Oct 30];191:74–81. Available from:
https://pubmed.ncbi.nlm.nih.gov/29032114/17. Katz A, Efros M, Kaminetsky J, Herrlinger K, Chirouzes D, Ceddia M. A green and black tea extract benefits urological health in men with lower urinary tract symptoms. Therapeutic Advances in Urology [Internet]. 2014 Mar 20 [cited 2024 Oct 30];6(3):89–96. Available from:
https://pmc.ncbi.nlm.nih.gov/articles/PMC4003843/21. Calogero AE, Burgio G, Condorelli RA, Cannarella R, Sandro La Vignera. Epidemiology and risk factors of lower urinary tract symptoms/benign prostatic hyperplasia and erectile dysfunction. The Aging Male [Internet]. 2018 Feb 2 [cited 2025 Jan 7];22(1):12–9. Available from:
https://pubmed.ncbi.nlm.nih.gov/29392976/28. Dickerman BA, Ahearn TU, Giovannucci E, Stampfer MJ, Nguyen PL, Mucci LA, et al. Weight change, obesity and risk of prostate cancer progression among men with clinically localized prostate cancer. International Journal of Cancer [Internet]. 2017 Jun 8 [cited 2025 Jan 7];141(5):933–44. Available from:
https://pmc.ncbi.nlm.nih.gov/articles/PMC5518616/